The present invention relates to salts of budesonide 21-phosphate with β2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.
BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME / Caliendo, G., Cirino, G., Fiorino, F., Frecentese, F., Muscara', M., Perissutti, E., Petti, A., Roviezzo, F., Santagada, V., Severino, B., Magli, E.. - (2021).
BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
CALIENDO GIUSEPPE;CIRINO GIUSEPPE;FIORINO FERDINANDO;FRECENTESE FRANCESCO;PERISSUTTI ELISA;ROVIEZZO FIORENTINA;SANTAGADA VINCENZO;SEVERINO BEATRICE;MAGLI ELISA
2021
Abstract
The present invention relates to salts of budesonide 21-phosphate with β2 adrenergic agonists, preferably with formoterol, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
WO2021191366A1.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Dominio pubblico
Dimensione
12 MB
Formato
Adobe PDF
|
12 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
